Merck, known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for $221.50 per sh…
SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced a global research and licensing collaboration with Eli Lilly and Company . The companies will collaborate to advance RNAi candidates for metabolic diseases, based on SanegeneBio's proprietary tissue selective deliver…
Brenntag, the global market leader in chemicals and ingredients distribution, announced a new and exclusive distribution agreement with ArcticZymes AS on the salt-active nucleases: SAN HQ, SAN-HQ GMP, M-SAN HQ, M-SAN HQ GMP, developed for the efficient removal of nucleic acids in gene therapy, vaccine production and o…
Complete Genomics, a leading innovator in genomic sequencing, announced a collaboration with SOPHiA GENETICS, a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden …
Evinova, a global health-tech company accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, and Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, announ…
NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medical University in Osaka, Japan. Under the guidance of Dr. Toshio Shimizu as the Director of the Phase I program, Kansai Medical University will now offer patients in Japan the opportunity to participa…
Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi, a global leader in AI drug discovery, announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and development of bispecific antibodies for the treatment of various diseases.…
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND", announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR-T cells. This agreement represents…
Insurance leader Vitality and Google today announced a global partnership to launch Vitality AI. This new platform will integrate Google Cloud's advanced AI and data analytics, with Vitality's vast health datasets and behavior-change expertise, to transform how millions worldwide understand and manage their health. Th…
Singapore-based Raffles Medical Group and Gene Solutions, headquartered in Vietnam, have signed a Memorandum of Understanding (MoU) to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia. Under this partnership, the Raffles Med…
Page 30 of 43